000 01428 a2200373 4500
005 20250514024621.0
264 0 _c20020530
008 200205s 0 0 eng d
022 _a0959-8049
024 7 _a10.1016/s0959-8049(01)00406-3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCressey, T R
245 0 0 _aDecreased telomerase activity is not a reliable indicator of chemosensitivity in testicular cancer cell lines.
_h[electronic resource]
260 _bEuropean journal of cancer (Oxford, England : 1990)
_cMar 2002
300 _a586-93 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aApoptosis
650 0 4 _aCisplatin
_xtherapeutic use
650 0 4 _aDoxorubicin
_xtherapeutic use
650 0 4 _aDrug Resistance, Neoplasm
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMelphalan
_xtherapeutic use
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
650 0 4 _aTelomerase
_xmetabolism
650 0 4 _aTeratoma
_xdrug therapy
650 0 4 _aTesticular Neoplasms
_xdrug therapy
650 0 4 _aTumor Cells, Cultured
700 1 _aTilby, M J
700 1 _aNewell, D R
773 0 _tEuropean journal of cancer (Oxford, England : 1990)
_gvol. 38
_gno. 4
_gp. 586-93
856 4 0 _uhttps://doi.org/10.1016/s0959-8049(01)00406-3
_zAvailable from publisher's website
999 _c11779835
_d11779835